EBD-DTI is presented, a framework that enables zero-shot inference in graph-based DTI models without requiring any known interactions for unseen entities, with episodic cold-start training improving AUC by up to 12%.
Abstract
Predicting drug–target interactions (DTI) for entirely unseen drugs or proteins—the cold-start problem—remains a critical challenge in computational drug discovery. While sequence-based methods naturally support zero-shot generalization, they often ignore relational topology, and existing graph-based approaches either rely on global diffusion that blurs the boundary between inductive and transductive evaluation or require a few known interaction samples at test time (few-shot). We present EBD-DTI, a framework that enables zero-shot inference in graph-based DTI models without requiring any known interactions for unseen entities. The key innovation is episodic cold-start training : at each epoch, a random subset of training entities is masked and treated as pseudo-cold, forcing the model to learn cold-start inference with explicit gradient supervision. A bridge-conditioned local subgraph, together with multi-hop diffusion, provides cold entities with relational context from their nearest observed neighbors. Experiments on three benchmarks (BioSNAP, BindingDB, and DrugBank) demonstrate that EBD-DTI achieves competitive or superior performance compared to state-of-the-art methods under strict zero-shot evaluation, with episodic training improving AUC by up to 12%.
The proposed ZSCAN-DDIE framework enhances prediction accuracy for unseen DDIE categories but also provides biologically meaningful insights into molecular interaction mechanisms, offering a robust and clinically relevant solution for pharmacovigilance and drug safety assessment.
Shao-Xi Gao, Zhan-Peng Gan, Fang-Fang Han et al.· Bioinformatics Advances· 0 citations
The accurate identification of drug–drug interaction (DDI) events (DDIEs) is essential for ensuring medication safety and preventing adverse effects. However, novel drug development constantly generates new DDIE classes that suffer from a severe scarcity of labels, making zero-shot learning an essential solution for...
Unknown authors· Journal of Chemical Informat...· 0 citations
Computational drug–target interaction (DTI) prediction provides a scalable alternative to costly and time-consuming experimental screening, but its reliability is limited by the scarcity of experimentally verified negative interactions. In public DTI databases, most unobserved drug–target pairs are unlabeled rather tha...
Shuai Guo, Weichi Liu, Jie Zou et al.· Frontiers in Bioinformatics· 0 citations
Predicting drug synergy is essential for optimizing combination therapies in cancer treatment. Under extreme data scarcity, existing computational methods struggle to generalize to new cell lines. Although meta-learning approaches have shown promise, a critical limitation lies in their reliance on a unimodal Gaussian p...
Shuting Jin, Xu Guo, Anqi Huang et al.· Proceedings of the 32nd ACM...· 0 citations
DQHTFI is proposed, a fine-grained interaction prediction framework for drug–target interaction classification and binding affinity regression that employs BRICS fragments and Pfam functional domains as the basic interaction units and jointly learns semantic and structural representations.
Ke Tao, Haoze Chai, Zhuo Chen et al.· bioRxiv· 0 citations
Drug–target interaction (DTI) prediction is a critical step in drug discovery, and accurate prediction of potential interactions can significantly accelerate the drug-development process. Although deep-learning approaches have achieved promising performance in DTI prediction, two challenges remain: single models often...
Qing-Chuan Xu, An-Ting Gao, Kai Che et al.· Electronics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.